Congratulations to the WVU Clinical trials Research Unit (CTRU) and Dr. Adham Salkeni, WVU’s principal investigator for the NRG Oncology group, the largest clinical trials collaborative network in the United States. During the recent biannual meeting of the NRG, our CTRU was recognized as among the top ten main member sites to enroll the most patients on cancer clinical trials between January and June 2017. “This places WVU on the national map for clinical trials accrual,” Salkeni said. “This shows that we offer state-of-the-art research studies that examine the role of targeted therapies for the treatment of a wide variety of cancers that affect our patient population.”
“Vaporized: America’s E-Cigarette Addiction,” a comprehensive look inside the rapidly growing and highly controversial vaping industry, a market expected to hit $9 billion by the end of 2019.
The Department of Diagnostic Sciences has developed a team of specialists aimed at raising awareness about oral cancer. The efforts include educating the public about the causes of oral cancer while promoting prevention and regular oral exams. In addition, the team maintains an active biopsy service staffed by pathologists trained specifically in the diagnosis of tumors of the mouth.
Some cancers are difficult to treat due to where they appear in the body. For some abdominal cancers, intravenous chemotherapy may not work because drugs flowing through the whole body don’t penetrate into the peritoneal cavity – the space surrounding your abdominal organs.